Abstract
Obesity is defined as excess body fat and results from an imbalance of energy intake and expenditure (1). This simple definition and the application of thermodynamic principles of energy balance do not adequately express the fact that much remains unknown about this complex disorder (2). In common with other chronic diseases including cancer, it is rare for obesity to be the expression of a pure genetic or medical disorder. In the majority of cases, obesity results from a combination of physiological, psychological and environmental factors (3). A genetic predisposition to obesity mediated by a large number of genes is likely to interact with a permissive high fat diet in the presence of reduced physical activity to result in obesity(4). Obesity is the most prevalent disorder in the United States affecting up to one-third of the population. The endocrine system which is critically involved in many common forms of cancer has also been shown to translate environmental influences into excess adiposity (5). Many hormones involved in obesity also play a role in the initiation and promotion of cancer both at a cellular, paracrine, and systemic level (6). For example, reproductive hormones are critically involved in both obesity and cancer. In patients with primary anorexia nervosa and malnutrition, reproductive hormone secretion is reduced and can result in infertility. Conversely, with obesity excess secretion of reproductive hormones (e.g. estrogens) has been observed and implicated in the etiology of breast cancer (7). This chapter will examine the potential role of hormones in the etiology of obesity in the hopes of stimulating additional research on the role of obesity in modulating the risk of developing several common forms of cancer.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Garrow JS. Energy balance and obesity in man. 2nd edition. Elsevier/North Holland Inc., New York, 1978, p. 243.
Bray GA. Obesity: a clinical and metabolic approach. Med. Clin. N. America 1989; 73:1–269.
Brownell KD, Foreyt JP (eds). Handbook of Eating Disorders. Physiology, Psychology, and Treatment of Obesity, Anorexia and Bulimia. Basic Books, New York.
Stunkard AJ, Sorensen TIA, Harris C. Adoption study of human obesity. New Engl J. Med. 1986; 314:193–198.
Heber D. Endocrinology of Obesity. In: Obesity: Pathophysiology, Psychology and Treatment. (G.Blackburn and B.S. Kanders, eds.) Andover Medical Publishers, Boston, 1994 pp. 98–110.
Heber D. Endocrine responses to starvation, malnutrition, and illness. In: DeGroot LJ, Besser M, Burger HG, Jameson LJ, Loriaux DL, Marshall JC, Odell WD, Potts JT, Rubenstein AH, eds. Endocrinology (3rd edition),W.B. Saunders, Philadelphia, 1994 pp. 2263–2678.
Heber D.The role of nutrition in cancer prevention and control.Oncology 1992; 6: 9–14.
Cloninger CR, Rice J, and Reich T. Multifactorial inheritance with cultural transmission and assortative mating II. A general model of combined polygenic and cultural inheritance. Am J Hum Genet. 1979; 31:176–198.
Chandra RK. The nutrition-immunity-infection nexis: The enumeration and functional assessment of lymphocyte subsets in nutritional deficiency. Nutr Res 1983; 3:605–615.
Bennett PH, Rushforth NB, Miller M, and Lecompte P. Epidemiologic studies of diabetes in the Pima Indians. Rec. Prog. Horm. Res. 1978; 108:497–452.
West, KM Epidemiology of Diabetes and its Vascular Complications. New York Elsevier 1978, p231.
West KM. Kalbfleisch, JM Influence of nutritional factors on prevalence of diabetes. Diabetes 1971; 20: 99.
Bagdade, JD, Bierman EL, Porte, D The significance of basal insulin levels in the evaluation of the insulin response to glucose in diabetic and nondiabetic subjects. J Clin Invest 1967; 46:1549.
Faber OK, Christensen, K, Kehlet, H et al Decreased insulin removal contributes to hyperinsulinemia in obesity. J Clin Endo Metab 1981; 53, 618.
Howard BV, Klimes I, Vasquez B et. al. The antilipolytic action of insulin in obese subjects with resistance to its glucoregulatory action. J Clin Endo Metab 1984; 58:544.
Ong JM, Kirchgessner TG, Schotz MC, Kern PA Insulin increases the synthetic rate and messenger RNA level of lipoprotein lipase in isolated rat adipocytes. J.Biol.Chem. 1988;263: 129–33.
Rodin J Insulin levels, hunger, and food intake: An example of feedback loops in body weight regulation. Health Psychol 1985;4:1–18.
Hartz, AJ, Barboriak, PH, Wong A et.al. The association of obesity with infertility and related menstrual abnormalities in women. Int J Obes 1987; 3:57.
Nimrod A, Ryan KH: Aromatization of androgens by human abdominal and breast fat tissue. J Clin Endo Metab 1975; 40:367.
Vague, J The degree of masculine differentiation of the obesities: A factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. Am J Clin Nutr 1956; 4:20.
Kissebah AH, Evans DJ, Peiris A, et al Endocrine characteristics in regional obesities: Role of sex steroids. In Vague J, Bjorntorp P, Guy-Grand B et al (eds).: Metabolic Complications of Human Obesities. Amsterdam, Excerpta Medica, 1985, p. 115.
Spain DM, Nathan DJ, Gellis M Weight, body type, and the prevalence of coronary atherosclerotic heart disease in males.Am J Med Sci 1963; 245: 63.
Rebuffe-Scrive M, Eldh J, Hafstrom LO et al Metabolism of mammary, abdominal, and femoral adipocytes in women before and after the menopause. Metabolism 1986; 35: 792–797.
Kerr MG: Significance of weight gain in pregnancy. Lancet 1969; 1: 663.
Rebuffe-Scrive M Metabolic differences in fat depots. In Bouchard C, Johnston FE (eds) Fat distribution during growth and later health outcomes. New York Alan R Liss 1988 p. 175.
Rebuffe-Scrive M, Enk L, Crona N et al Fat cell metabolism in different regions in women. J Clin Invest 1985; 75: 1973–1976.
Leibel RH, Hirsch J Site and sex-related differences in adrenoreceptor status of human adipose tissue. J Clin Endo Metab 1987; 64: 1205–1210.
Lyons, PM, Truswell AS, Mira M, et al Reduction of food intake in the ovulatory phase of the menstrual cycle. Am J Clin Nutr 1989; 49: 1164–1168.
Tchekmedyian NS, Hickman M, and Heber D Treatment of anorexia and weight loss in patients with cancer or acquired immunodeficiency syndrome. Sem in Oncol 1991; 18:35–42.
Pike MC, Krailo MD, Henderson BE, et al. “Hormonal” risk factors, “breast tissue age”, and the age-incidence of breast cancer. Nature 1983; 303:767–770.
Pike MC, Spicer DV, Dahmoush L, et al. Estrogens, progestogens, normal breast cell proliferation and breast cancer risk. Epidemiol Rev 1993; 15:17–35.
Kelsey JL. A review of the epidemiology of human breast cancer. Epid Rev 1979; 1: 74–109.
Prentice R, Thompson D, Clifford C, Gorbach S, Goldin B, Byar D. Dietary fat reduction and plasma estradiol concentration in healthy postmenopausal women. JNCI 1990;82:129–134.
Heber D, Ashley JM, McCarthy WJ, Chang C-J, Elashoff R. Assessment of adherence to a low fat diet for breast cancer prevention. Prev Med 1992; 21:218–227.
Bagga D, Ashley JM, Geffrey S, Barnard JA, Wang H-J, Korenman S, Heber D. Effects of very low fat high fiber diet on reproductive hormones:Implications for breast cancer prevention. Cancer 1995; 22: 351–355.
Reichman ME, Judd JT, Longcope C, Schatzkin A, Clevidence BA, Nair PP, Campbell WS, Taylor PR. Effects of alcohol consumption on plasma and urinary hormone concentrations in premenopausal women. JNCI 1993; 85:722–726.
Grodin JM, Siiteri PK, MacDonald PC. Source of estrogen production in postmenopausal women. J Clin Endocrinol Metab 36:207–210, 1973.
Siiteri PK, MacDonald PC. Role of extraglandular estrogen in human endocrinology. In: Greep RO, Astwood EB,eds. Handbook of Physiology Sec.7, vol.2, part 1 Wash. D.C.Am Physiol Soc 1973; 15–629.
Schindler AE, Ebert A, Friedrich E. Conversion of androstenedione to estrone by human fat tissue. J Clin Endo Metab 1972; 35:627–630.
Simpson ER, Ackerman GE, Smith ME. Estrogen formation in stromal cells of adipose tissue of women: induction by glucocorticoids. Proc Nat Acad Sei 1981; 73:5690–5694.
Zumoff B. Relationship of obesity to blood estrogens. Cancer Res.(suppl) 1982; 42:3289–3294.
Kalish L. Relationship of body size with breast cancer. J Clin Oncol 1984; 2:287–293.
Abe R, Kumagai N, Kimura M. Biological characteristics of breast cancer in obesity. Tohoku J Exp Med 1976;120:351–9.
Donegan WL, Hartz AJ, Rimm AA. The association of body weight with recurrent cancer of the breast. Cancer 1978;41:1590–1594.
Howson CP, Kinne D, Wynder EL. Body weight, serum cholesterol and stage of primary breast cancer. Cancer 1986;58:2372–2381.
deWaard F. Epidemiology of breast cancer: a review. Eur J Clin Oncol 1983;19:1671–1676.
Verreault R, Brisson J, Deschenes L, Naud F. Body weight and prognostic indicators in breast cancer. Am J Epidem 1989; 129: 260–268.
Camoriano JK, Loprinzi CL, Ingle JN, Therneau TM, Krook JE, Veeder MH Weight change in women with adjuvant therapy or observed following mastectomy for node-positive breast cancer. J Clin One 1990; 8: 1327–1334.
Tretli S Height and weight in relation to breast cancer morbidity and mortality. A prospective study of 570,000 women in Norway. Int J Cancer 1989; 44: 23.
Newman SC, Miller AB, and Howe GR A study of the effect of weight and dietary fat on breast cancer survival time. Am J Epidemiol 1986; 123: 767.
deWaard F, Poortman J, Collette B J Relationship of weight to promotion of breast cancer after menopause. Nutr Cancer 1981; 2: 237–240.
McNee RK, Mason BH, Neave LM et al Influence of height, weight,and obesity on breast cancer incidence and recurrence in Auckland,New Zealand Breast Cancer Res Treat 1987; 9:145.
Eberlein I, Simon R, Fisher S et al Height, weight, and risk of breast cancer relapse. Breast Cancer Res Treat 1985; 5:81.
Hebert JR, Augustine A, Barone J, Kabat GC, Kinne DW, Wynder EL. Weight, height, and body mass index in the prognosis of breast cancer: early results of a prospective analysis. 1988; 42:315.
Lubin F, Ruder AM, Wax Y, Modan B. Overweight and changes in weight throughout adult life in breast cancer etiology. A case-control study. Am J Epidemiol 1985; 122:579.
Le Marchand, L, Kolonel LN, Earle ME, Mi MP. Body size at different periods of life and breast cancer risk. Am J Epidemiol 1988; 128: 137.
London SJ, Colditz GA, Stampfer MJ, et al. Prospective study of relative weight, height and risk of breast cancer. JAMA 1989; 262: 2853.
Ballard-Barbash R, Schatzkin A, Carter CL, et al Body fat distribution and breast cancer in the Framingham study. J Natl Cancer Inst 1990; 82: 286.
Reichman ME, Judd JT, Taylor PR, Nair PP, Jones DY, Campbell WS. Effect of Dietary Fat on Length of the Follicular Phase of the Menstrual Cycle in a Controlled Diet Setting. J Clin Endo Metab 1992; 74:1171–1175.
Rose DP, Boyar AP, Cohen C et al. Effect of a low-fat diet on hormone levels in women with cystic breast disease. I. Serum steroids and gonadotropins. J Nat Cancer Inst 1987; 78:623–9.
Rose DP, Goldman M, Connolly J, et al. High fiber diet reduces serum estrogen concentrations in premenopausal women. Am J Clin Nutr 1989; 49:1179–1183.
Woods MN, Gorbach SL, Longcope C, Goldin BR, et al. Low fat, high fiber diet and serum estrone sulfate in premenopausal women. Am J Clin Nutr 1989; 49:1179–1183.
Bernstein L, Yuan J-M, Ross RK, Pike MC, Hanisch R, Lobo R, Stanczyk F, Gao Yu-T, Henderson BE. Serum hormone levels in pre-menopausal Chinese women in Shanghai and white women in Los Angeles: results from two breast cancer case-control studies. Cancer Causes and Control 1990; 1:51–58.
Smals AGH, Kloppenberg PWC, Benraad TJ: Body proportions and androgenicity in relation to plasma testosterone levels in Klinefelter’s syndrome. Acta Endocrinol 1974; 77:387.
Odell WD Isolated deficiencies of anterior pituitary hormones: symptoms and diagnosis. J Am Med Assoc 1966; 197:1006.
Vermeulen, A, Verdonck L: Sex hormone concentrations in postmenopausal women. Relation to obesity, fat mass, age, and years postmenopause. Clin Endocrinol 1978; 9: 59.
Arendt EC, Pattee CJ: Studies on obesity. I. The insulin-glucose tolerance curve. J Clin Endocrinol 1956: 16:367.
Meistas MT, Foster GV, Margolis S et al: Integrated concentrations of growth hormone, insulin, C-peptide and prolactin in human obesity. Metabolism 1982; 31: 1224.
Kopelman PG, Noonan K, Goulton R et al; Impaired growth hormone response to growth hormone releasing factor and insulin in obesity. Clin Endocrinol 1985; 23: 87.
Kalucy RS Crisp AH Chart T Nocturnal hormonal profiles in massive obesity, anorexia nervosa and normal females. J Psychosom Res 1976; 20: 595.
Beck P, Koumans JHT, Winterling CA et al; Studies of insulin and growth hormone secretion in human obesity. J Lab Clin Med 1964; 64:454.
Rabinowitz D, Merimee T, Nelson JK: The hormonal profile in obesity. Trans Assoc Am Physicians 1967; 80:190.
Hansen AP: Serum growth hormone repsonse to exercise in nonobese and obese normal subjects. Scand J Clin Lab Invest 1973; 31:175.
Londono, JH, Gallagher TF, Bray GA: Effect of weight reduction, triiodothyronine, and diethylstilbestrol on growth hormone in obesity. Metabolism 1969; 18:986.
Kelijman M, Frohman LA: Enhanced growth hormone responsiveness to GH — releasing hormone after dietary manipulation in obese and non-obese subjects. J Clin Endo Metab 1988; 66:489.
Loche S, Cappa M, Berrelli P et al Reduced growth hormone response to growth hormone releasing hormone in children with simple obesity: Evidence for somatomedin-C mediated inhibition. Clin Endocrinol 1987; 27:145.
Sims EAH, Horton ES: Endocrine and metabolic adaptation to obesity and starvation. Am J Clin Nutr 1968; 21:1455.
Crockford PM, Salmon PA: Hormones and obesity: changes in insulin and growth hormone secretion following surgically induced weight loss. Can Med Assoc J 1970; 103: 147.
Williams T, Berelowitz M, Joffe SN et al Impaired growth hormone responses to growth hormone releasing factor in obesity: a defect reversed with weight reduction. N Engl J Med 1984; 331:1403.
Rosskamp R, Becker M, Soetadji S: Circulating somatomedin-C levels and the effect of growth hormone releasing factor on plasma levels of growth hormone and somatostatin-like immunoreactivity in obese children. Eur J Pediatr 1987; 146:48.
Wilcox RG Triiodothyronine, TSH, and prolactin in obese women. Lancet 1977; 1: 1027.
Cavagnini F, Maraschini C, Pinto M et al: Impaired prolactin secretion in obese patients. J Endocrinol Invest 1981; 4:149.
Kopelman PG, White N, Pilkington TRE: Impaired hypothalamic control of prolactin secretion in massive obesity. Lancet 1979; 1:747.
Kopelman PG, Pilkington TRE, White N, et al Persistence of defective hypothalamic control of prolactin secretion in some obese women after weight reduction. Br MEd J 1980; 281:358.
Atkinson RL, Dahms WT, Bray GA et al: Parathyroid hormone levels in obesity: Effects of intestinal bypass surgery. Min Electr Metab 1978; 1:315.
Bell NH, Epstein S, Greene A et al: Evidence for alteration of the vitamin D-endocrine system in obese subjects. J Clin Invest 1985; 76:370.
Glass AR, Swerdloff RS, Bray GA, et al: Low serum testosterone and sex hormone binding globulin in massively obese men. J Clin Endocrinol Metab 1977; 45:1211.
Amatruda JM, Harman SM, Pourmotabbed G et al:Depressed plasma testosterone and fractional binding of testosterone in obese males. J Clin Endo Metab 1978; 47:268.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Plenum Press, New York
About this chapter
Cite this chapter
Heber, D. (1996). Interrelationships of High Fat Diets, Obesity, Hormones, and Cancer. In: Heber, D., Kritchevsky, D. (eds) Dietary Fats, Lipids, Hormones, and Tumorigenesis. Advances in Experimental Medicine and Biology, vol 399. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1151-5_2
Download citation
DOI: https://doi.org/10.1007/978-1-4613-1151-5_2
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8450-5
Online ISBN: 978-1-4613-1151-5
eBook Packages: Springer Book Archive